<DOC>
	<DOCNO>NCT02269878</DOCNO>
	<brief_summary>To Study Effect Polymorphisms Fas Ligand Gene Promoter Region ( rs 763110 ) Fas gene ( rs1800682 ) Platinum-Based regimen use treatment malignant pleural mesothelioma ( MPM )</brief_summary>
	<brief_title>Effect FAS FAS Ligand Polymorphisms Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma</brief_title>
	<detailed_description>This study try find correlation single nucleotide polymorphism ( SNP ) find promoter region Fas Ligand gene ( rs 763110 ) Fas ( rs1800682 ) clinical outcome patient MPM treat platinum-Based agent first line . patient one three follow genotype : Thymine/Thymine , Thymine/Cytosine Cytosine/Cytosine ( Fas ligand polymorphism ) Adenine/Adenine , Adenine/Guanine Guanine/Guanine ( Fas polymorphism ) .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<criteria>Patients histologically confirm Malignant Pleural Mesothelioma Age 18 year . firstline chemotherapy platinumBased agent history prior malignancy . pregnancy lactation reason prevent take platinumBased chemotherapy ( AST 2.5* Upper Limit Normal Serum bilirubin 1.5* Upper Limit Normal )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>